Prospective study to evaluate the effects of sildenafil 50 mg/day for 28 days in patients with erectile dysfunction (ED), and lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH);Estudio prospectivo para valorar el impacto del sildenafilo 50 mg/día durante 28 días en pacientes con disfunción eréctil y sintomatología del tracto urinario inferior secundaria a hiperplasia benigna de próstata

Revista Internacional de Andrologia

Volumn 6, Issue 2, 2008, Pages 84-88

  Vozmediano Chicharro, Raúl ^a   Soler Martínez, Jorge ^a   Morales Jiménez, Pedro ^a   Hernández Alcaráz, David ^a   Blanco Reina, Francisco ^a   Baena González, Víctor ^a   Martín Morales, Antonio ^a  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

BPH; ED; LUTS; Sildenafil

Indexed keywords

EID: 63149174822     PISSN: 1698031X     EISSN: 16980409     Source Type: Journal    
DOI: 10.1016/S1698-031X(08)75675-9     Document Type: Article

References (24)

1. Chicharro-Molero J.A., Burgos-Rodríguez R., Sánchez-Cruz J.J., Del Rosal-Samaniego J.M., Rodero-García P., and Rodriguez-Vallejo J.M. Prevalence of benign prostatic hyperplasia in spanish men 40 years old or older. J Urol 159 (1998) 878-882
2. Martín-Morales A., Sánchez-Cruz J.J., Saenz deTejada I., Rodríguez-Vela L., Jiménez-Cruz J.F., and Burgos-Rodríguez R. Prevalence and independent risk factors for erectile dysfunction in spain: results of the Epidemiología de la Disfunción Eréctil Masculina Study. J Urol 166 (2001) 569-575
3. Rosen R., Altwein J., Boyle R., Kirby R.S., Lukacs B., Meuleman E., et al. Lower urinary tract symptoms and male sexual disfunction: the Multinacional Survey of Agging Male (MSAM-7). Eur Urol 44 (2003) 637-649
4. Hansen B.L. Lower urinary tract symptoms (LUTS) and sexual function in both sexes. Eur Urol 46 (2004) 229-234
5. Braun M.H., Sommer F., Haupt G., Mathers M.J., Reifenrath B., and Engelman U.H. Lower urinary tract symptoms and erectile dysfunction: co-morbidity or typical "aging Male"symptoms? Results of the "cologne Males Survey"?. Eur Urol 44 (2003) 588-594
6. Vallancien G., Emberton M., Harving N., and Van Moorselaar R.J. Sexual dysfunction in 1274 European men suffering from lower urinary tract symptoms. J Urol 169 (2003) 2257-2261
7. Martín-Morales A., García-Galisteo E., García-Galisteo J., Chicharro-Molero J.A., Fernández-Ajuria A., Sánchez-Cruz J.J., et al. Lower urinary tract symptoms (luts) and erectile dysfunction (ed) in a population based survey. Data from the edem* study. Int J Impot Res 3 Supp 4 S39 (2001) ESSIR Meeting Roma; 2001
8. Montague D.K. Can sildenafil rise to the occasion in BPH?. Consultant 40 (2000) 870
9. Ückert S., Küthe A., Jonas U., and Stief C.G. Characterization and functional relevance of cyclic nucleotide phosphodiesterase isoenzymes of the human prostate. J Urol 166 (2001) 2484-2490
10. Carson C.C. Combination of phosphodiesterase-5 inhibitors and alpha-blockers in patients with benign prostatic hyperplasia: treatments of lower urinary tract symptoms, erectile dysfunction, or both?. BJU Int 97 Suppl 2 (2006) 39-43 discussion 44-5
11. Uckert S., Kuthe A., Jonas U., and Stief C.G. Characterization and functional relevance of cyclic nucleotide phosphodiesterase isoenzymes of the human prostate. J Urol 166 (2001) 2484-2490
12. Moelli A., Filippi S., Mancina R., et al. Androgens regulate phosphodiesterase type 5 expression and functional activity in corpora cavernosa. Endocrinology 145 (2004) 2253-2263
13. Rosen R.Cl., Riley A., Wagner G., Osterloh I.H., Kirkpatrick J., and Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 49 (1997) 822-830
14. Vela-Navarrete R., Martín Moreno J.M., Calahorra P.J., Damián-Moreno J., Hernández-Coronado A., and Boyle P. Validación cultural y lingüística en castellano del Índice Internacional de Sintomatología Prostática (IPSS). Arch Urol Esp 8 (1994) 841-847
15. Frankel S.J., Donovan J.L., Peters T.I., Abrams P., Dabhoiwala N.F., Osawa D., et al. Sexual dysfunction in men with lower urinary symptoms. J Clin Epidemiol 51 (1998) 677-685
16. Rosen R., Altwein J., Boyle P., Kirby R.S., Lukacs B., Meuleman E., et al. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol 44 (2003) 637-649
17. Aslan G., Cavus E., Karas H., Oner O., Duran F., and Esen A. Association between lower urinary tract symptoms and erectile dysfunction. Arch Androl 52 (2006) 155-162
18. Seftel A. Correlation between LUTS (AUA-SS) and erectile dysfunction (SHIM) in an age-matched racially diverse male population: data from the prostate cancer awareness week (PCAW). J Urol 174 (2005) 1941
19. Braun M.H., Sommer F., Haupt G., Mathers M.J., Reifenrath B., and Engelmann U.H. Lower urinary tract symptoms and erectile dysfunction: co-morbidity or typical "Aging Male" symptoms? Results of the "Cologne Male Survey". Eur Urol 44 (2003) 588-594
20. Costabile R.A., and Steers W.D. How can we best characterize the relationship between erectile dysfunction and benign prostatic hyperplasia?. J Sex Med 3 (2006) 676-681
21. McVary K.T. Interrelation of erectile dysfunction and lower urinary tract symptoms. Drugs Today (Barc) 41 (2005) 527-536
22. McVary K.T. Erectile dysfunction and lower urinary tract symptoms secondary to BPH. Eur Urol 47 (2005) 838-845 Epub 2005 Feb 22
23. Sairam K., Kulinskaya E., McNicholas T.A., Boustead G.B., and Hanbury D.C. Sildenafil influences lower urinary tract symptoms. BJU Int 90 (2002) 836-839
24. Mulhall J.P., Guhring P., Parker M., and Hopps C. Assessment of the impact of sildenafil citrate on lower urinary tract symptoms in men with erectile dysfunction. J Sex Med 3 (2006) 662-667